Fasalka Farmasiga Nadiifinta Sare 25316-40-9 Doxorubicin Hydrochloride ee Daaweynta Kansarka
| Alaabtamagac | Doxorubicin Hydrochloride |
| La mid ah | (8S-cis)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy -8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride |
| CAS Maya. | 25316-40-9 |
| Muuqashada | Orange-cas ama budada crystalline cas |
| Qaanuunka molecular | C27H29NO11.HCl |
| Miisaanka Molecular | 579.99 |
| Isticmaalka | Darajada daawada ama ujeedada cilmi baarista |
| Baakad | Sida ku cad codsigaaga |
| Kaydinta | Ku kaydi weel cidhiidhi ah oo iftiin u adkaysta meel qabow |
| Magaca Alaabta: Doxorubicin Hydrochloride Lambarka CAS:25316-40-9 | ||
| WAXYAABAHA | HEERARKA | NATIIJADA |
| Muuqashada | Orange-cas ama budada crystalline cas;Ma jiro caddayn muuqata oo ku saabsan wasakhaynta walxaha shisheeye | U hogaansama |
| Solubility | Ku milmay biyaha iyo methanol;wax yar oo ku milma ethanol;ficil ahaan aan lagu milmi karin acetone. | U hogaansama |
| Aqoonsiga | A: IR spectrum waxay u dhigantaa spectrum IR ee heerka tixraaca | U hogaansama |
| B: Waqtiga haynta ee ugu sarreysa doxorubicin ee chromatogram-ka diyaarinta Assay u dhiganta tan ku jirta chromatogram-ka Diyaarinta caadiga ah, sida lagu helay Assay. | U hogaansama | |
| pH | 4.0 ilaa 5.5 | 4.9 |
| Biyo | Aan ka badnayn 4.0% | 2.1% |
| Walxaha laxidhiidha | wasakh A (Doxorubicinone) ≤0.5% | 0.23% |
| Wax kasta oo kale oo aan la garanayn ≤0.2% | 0.17% | |
| Wadarta wasakhda aan la garanayn ≤0.5% | 0.37% | |
| Wadarta wasakhda ≤2.0% | 0.6% | |
| Xalalka Haraaga ah | Acetone ≤ 0.5% Acetone + ethanol ≤ 2.5% methanol ≤ 0.3% Dichloromethane ≤ 0.06% | 0.34% 1.6% 0.07% Lama ogaan |
| Qiimayn | 98.0% ~ 102.0% | 99.2% |
| Gabagabo: Natiijooyinku waxay waafaqayaan heerka USP34. | ||
Macluumaadka Shirkadda
√ Waayo-aragnimada buuxda ee lakabka maamulka ee warshadda iyo farsamayaqaannada raacsan; √ Tayada had iyo jeer waa tixgelinteena ugu sareysa, nidaamka QC adag; √ 11 sano oo khibrad u leh kooxda iibka dhoofinta; √ shaybaadhka R&D ee madaxa banaan; √ Laba aqoon-is-weydaarsiyo GMP-dheer oo saxeexan; √ Khayraadka hodanka ah ee warshado badan oo shaqo la'aan ah oo loogu talagalay mashruuc la habeeyey; √ Kooxda shaqada oo hufnaan sare leh oo leh waddo joogto ah.
